Leaders in Life Sciences – #11 Peter van Dijken
Peter van Dijken, Managing Director Gezond Leven at TNO.
7 March 2023
Leaders in Life Sciences – #11 Peter van Dijken
Peter van Dijken, Managing Director Gezond Leven at TNO.
Press release: Reaching big heights at Pivot Park
The new Grizzly building has reached it’s highest point at Pivot Park this week. Grizzly provides space for offices and laboratories. This space is much needed, because successful start-ups and scale-ups are outgrowing their space. With the arrival of Grizzly, Pivot Park stimulates innovation and employment. Companies will have the space and facilities to develop further. This allows them to excel further and to continue to play a leading role worldwide in the field in which they operate.
Leaders in Life Sciences – #10 Pieter van der Meer
Pieter van der Meer, Managing Partner Gilde Healthcare
“It was a revelation for me. As Accountants, we usually look back at the end of every year. But to work with partners in Life Science we needed a change of mind set. We wanted to collaborate and facilitate more, to help our clients achieve their goals. We think along with our clients and help them build healthy, growing companies.”
Leaders in Life Sciences – #7 Paul Stoffels & Michel van Agthoven
Paul Stoffels is CEO van Galapagos en Michel van Agthoven is Lead Janssen Campus the Netherlands en director external affairs Netherlands bij Janssen.
Leaders in Life Sciences – #6 Tom Oostrom
Tom Oostrom is directeur van de Nierstichting.
Leaders in Life Sciences – #5 Annemiek Verkamman
Annemiek Verkamman is directeur van HollandBIO.
Acerta: Biggest biotech deal ever in the Netherlands
Pharmaceutical companies regularly come shopping in the Netherlands with a large bag of money. These pharmaceutical companies often buy the rights to a promising drug, and that’s always a bit of a gamble. An experimental drug is quickly promising, but the promise is not always fulfilled.
Leaders in Life Sciences – #4 Hanneke Schuitemaker
Hanneke Schuitemaker is Global Head of Viral Vaccine Discovery and Translational Medicine bij Janssen Pharmaceuticals.
100 jaar medicijn ontwikkeling in Oss.
Dit jaar vieren we dat er al 100 jaar medicijnen worden gemaakt in Oss. Een mijlpaal waar we trots op zijn en die we vieren met een themajaar.
The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.
Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.
This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.
We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.
Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.